More importantly, knockdown of METTL3 or METTL14 extensively reduced the increase of CCA stem-like properties, including the number of mammospheres and the expression of CD133 in mammospheres, which were triggered by IL-6 treatment in CCA cells (Figure 2H, 2I). Here, PROM1 is linked to cholangiocarcinoma.